Articles On MGC Pharmaceuticals (ASX:MXC)

Title Source Codes Date
MGC Pharma announces exciting new developments in the fight against COVID-19

European-based biopharma company MGC Pharmaceuticals (ASX:MXC) has just announced exciting further results from the Phase II clinical trials and pre-clinical studies of ArtemiCTM, for the treatment of COVID-19 patients. These studies are ev...

Stockhead MXC 7 hours ago
MGC Pharmaceuticals shares boosted by latest ArtemiC results in COVID-19 study

The mechanism of action of ArtemiC is focused on the anti-inflammatory effect and prevention of cytokine storm

Proactive Investors MXC 2 days ago
Last Orders: ASX 200 rebounds, but the IT sector slumps 10 per cent for the week

The ASX 200 has rebounded from yesterday’s loss though the technology sector has weighed on the market for two consecutive weeks. The index closed 0.20 per cent higher, and is also up by 0.70 per cent for the week. IT slumped by another 2.5...

Stockhead MXC 2 days ago
Last Orders: Tech leads the ASX into negative territory

The ASX finished the day in the red and the tech sector dropped more than any other sector. The ASX 200 closed at 7,062 which was 0.48 per cent down from yesterday and tech stocks shed over 3.5 per cent. The only other sector to fall over 1...

Stockhead MXC 3 days ago
MGC Pharmaceuticals in trading halt pending announcement by the company on ArtemiC™

Its securities will remain halted until the start of normal trading on Monday, May 10, 2021, or until an announcement is released to the market.

Proactive Investors MXC 3 days ago
3 ASX-listed cybersecurity stocks under the spotlight

Summary The increase in the level of digitisation has led to a rise in the number of scams in Australia, resulting in substantial financial losses. archTIS signed an agreement with the Australian Department of Defence for software supp...

Kalkine Media MXC 5 days ago
MGC pockets $1 million from COVID-19 supplement order

MGC Pharmaceuticals has secured a $1 million order for its COVID-19 supplement ArtemiC Rescue from nutraceuticals producer and distributor Swiss PharmaCan AG. The purchase marks the second major wholesale order since entering an exclusive a...

The West MXC 5 days ago
MGC Pharmaceuticals wins A$1 million order for ArtemiC Rescue

Phase 2 trials have shown ArtemiC’s ability to reduce symptoms and pain associated with COVID-19 and achieve faster clinical improvements.

Proactive Investors MXC 6 days ago
MGC Pharma builds on momentum with a new $1 million order

European-based biopharma company MGC Pharmaceuticals (ASX:MXC) has just received $1 million worth of orders for its ArtemiCTM Rescue food supplement. The order was received from its distribution partner Swiss PharmaCan (SPC), and is the sec...

Stockhead MXC 6 days ago
Did the March quarter updates for 5GN, JBH, CPT bring cheer to the market?

Summary 5G Networks reported robust growth across all three core products in Q3 FY21 and witnessed a growing demand for the 5GN Voice Bridge One Microsoft Teams product. JB Hi-Fi witnessed double-digit sales growth in two of its three...

Kalkine Media MXC 1 week ago
ASX healthcare shares OVN and ECS trading in red despite positive March quarter 

Summary Oventus Medical witnessed growth in booked revenue and acceleration in telehealth bookings in Q3 FY21. ECS Botanics Holdings’ March 2021 quarter was action-packed with a major acquisition and multiple supply agreements. Despit...

Kalkine Media MXC 1 week ago
Five stocks that made a buzz today

Summary MGC Pharmaceuticals rallied by 8.7% to A$0.062 as its Canada-based North American distribution partner is seeking product licences. Hexagon Energy is in news as it has agreed to select Air Products and Chemicals Inc as its key...

Kalkine Media MXC 1 week ago
MGC’s COVID-19 treatment spray takes big step forward in North America

The ASX-listed bio-pharma company’s Canadian distribution partner — which it collaborated with to create an oral spray statistically shown to improve the recovery of patients with COVID-19 — has now applied for additional product licences i...

Stockhead MXC 1 week ago
MGC Pharmaceuticals' North American distribution partner submits application to Health Canada for ArtemiC™

Glow LifeTech has exclusive rights to market, sell and distribute ArtemiC™ in Canada, USA, Mexico and all Caribbean countries as a food supplement (nutraceutical, dietary supplement, natural health product).

Proactive Investors MXC 1 week ago
Respiri (ASX:RSH) shares flying high on TerryWhite Chemmart partnership

Summary Respiri Limited has partnered with Australia’s largest pharmacy network, TerryWhite Chemmart, for the sale and marketing of wheezo™. This agreement brings the total number of pharmacies contracted to stock and sell wheezo to 1,...

Kalkine Media MXC 1 week ago
Why the MGC Pharma (ASX:MXC) share price has rocketed 9%

MGC Pharmaceuticals Ltd (ASX: MXC) is one to watch this afternoon. The MGC Pharma share price has climbed 8.8% higher today and provided an afternoon product update. Why is the MGC Pharma share price charging? MGC Pharma yesterday provided...

Motley Fool MXC 1 week ago
How did these three ASX stocks fare in Q3 FY21 – GSS, DW8, AR9

Summary Several ASX-listed companies have released their quarterly results in the last few days, attracting significant market attention. Genetic Signatures reported strong quarterly and YTD sales driven by the increasing demand for it...

Kalkine Media MXC 1 week ago
How did ASX healthcare shares MXC and RAC perform in March 2021 quarter?

Summary Medicinal cannabis player MGC Pharmaceuticals has a historic quarter with the ground-breaking achievement of listing on the LSE. Oncology company Race Oncology has an action-packed quarter with significant progress on the Three...

Kalkine Media MXC 1 week ago
MGC Pharmaceuticals’ “historic” March quarter highlighted by LSE listing and record sales

MGC Pharma became the first medicinal cannabis company to list on the London Stock Exchange, amid record sales of its phytomedicines.

Proactive Investors MXC 1 week ago
Dimerix (ASX:DXB) advances COVID-19 Phase 3 study, enrols multiple patients

Summary Drug discovery company developing new therapies, Dimerix, has enrolled multiple patients in REMAP-CAP study in Europe. In the ACE2 RAS study domain, subjects will be randomised to receive one RAS blockade strategy or control....

Kalkine Media MXC 2 weeks ago
A glance at 2 ASX penny shares  - MGC Pharmaceuticals and archTIS

Summary Australian players MGC Pharmaceuticals and ArchTIS limited were under the spotlight following recent crucial developments. Biopharma player MGC Pharma announced the acquisition of MediCaNL that is likely to deliver cost savings...

Kalkine Media MXC 2 weeks ago
MGC Pharmaceuticals' acquires MediCaNL to create an 'in-house research programme'

Proactive Investors MXC 2 weeks ago
MGC snaps up international medical research company

ASX-listed MGC Pharmaceuticals has snapped up clinical and medical research company MediCaNL which will now conduct all clinical trials as an internal unit of the company. The acquisition is expected to produce significant cost savings and...

The West MXC 2 weeks ago
MGC Pharma acquires clinical trials research company MediCaNL

MGC Pharma to bring clinical trials research company MediCaNL’s services in-house Transaction is for $6m in MGC Pharma shares and will deliver significant cost savings and advantages ‘The acquisition of MediCaNL is a strategically importan...

Stockhead MXC 2 weeks ago
Why the MGC Pharmaceuticals (ASX:MXC) share price is up 5% today

The MGC Pharmaceuticals Ltd (ASX: MXC) share price is soaring today after news the company will acquire clinical research company, MediCaNL Inc. MediCaNL will design, manage and run the biopharma company’s future clinical trials. The MGC P...

Motley Fool MXC 2 weeks ago
MGC Pharmaceuticals to acquire worldwide clinical and medical research company MediCaNL

The acquisition leverages the medical research expertise in-house which will reduce preclinical lead times, provide the ability to better define clinical trial protocols and build stronger relationships with regulators moving forward.

Proactive Investors MXC 2 weeks ago
Health House Seals Distribution Deal for Dragonfly Medicinal Cannabis Products 

Summary Health House International has signed a non-exclusive distribution agreement with Dragonfly Biosciences. The agreement with Dragonfly would strengthen Health House’s product portfolio within Australia. The distribution agreeme...

Kalkine Media MXC 2 weeks ago
Why are Australian cannabis shares APH and LGP on the rise?

Source: photolona, Shutterstock Summary Australian Primary Hemp has signed another retail distribution agreement with Coles Group Limited. Cannabis player Little Green Pharma has entered into a non-exclusive distribution agreement wit...

Kalkine Media MXC 2 weeks ago
MGC Pharmaceuticals poised to supply global phytocannabinoid market with growing patient base and global distribution footprint

MGC Pharma, which has three investigational medical products in three clinical trials, has reported a record quarter of sales and revenue.

Proactive Investors MXC 3 weeks ago
Weed Week: Australian medical cannabis prescriptions are soaring

The number of medical cannabis prescriptions issued under Australia’s special access scheme just keeps on growing. There were a record 9,959 SAS Category B marijuana prescriptions issued in March, two and a half times the number from a year...

Stockhead MXC 1 month ago
MGC Pharma banks record $880,000 in quarterly revenue

ASX and LSE-listed MGC Pharmaceuticals has banked a record $880,000 in quarterly revenue from sales of its phytomedicine products after delivering the first major batch of its ArtemiC Rescue anti-inflammatory formulation to Swiss PharmaCan...

The West MXC 1 month ago
3 Australian healthcare shares on the rise – BDA, MXC and IMM

Source: DG PhotoStock, Shutterstock Summary ASX-cannabis player Bod Australia has obtained a binding purchase order (PO) for CBD products in the US. Another cannabis player, MGC Pharmaceuticals, has completed the delivery of the first...

Kalkine Media MXC 1 month ago
MGC Pharma delivers first batch order to Swiss PharmaCan, notches record sales quarter

Medicinal cannabis biotech company MGC Pharmaceuticals (ASX:MXC) has delivered the first batch of purchase orders for its ArtemiCTM Rescue from Swiss PharmaCan AG (SPC). The total order is worth $425,000 (around 275k euros) of wholesale rev...

Stockhead MXC 1 month ago
Why the MGC Pharma (ASX:MXC) share price is zooming 13% higher today

The MGC Pharmaceuticals Ltd (ASX: MXC) share price is off to the races today, up 13% at the time of writing. The bio-pharma company produces and develops cannabis-derived medicines. Let’s take a look at the ASX cannabis share’s latest prod...

Motley Fool MXC 1 month ago
MGC Pharma cleared for Phase III trial of COVID-19 treatment

Bio-pharma company, MGC Pharmaceuticals has received ethics committee approval from two Israeli hospitals for a Phase III clinical trial of its trademarked “CimetrA” anti-inflammatory treatment on a large group of moderately sick, hospitali...

The West MXC 1 month ago
MGC Pharmaceuticals (ASX:MXC) and Respiri (ASX:RSH) secure key approvals

Source: create jobs 51, Shutterstock Summary MGC Pharmaceuticals has received approval from the Ethics Committee for Phase 3 clinical trial of CimetrATM in COVID-19 patients. eHealth SaaS player Respiri Limited has obtained US FDA’s a...

Kalkine Media MXC 1 month ago
Why the MGC Pharmaceuticals (ASX:MXC) share price is jumping 8%

MGC Pharmaceuticals (ASX: MXC) shares are on the rise today after the company advised two ethics committees have passed its product for phase III clinical trials on COVID-19 patients. At the time of writing, the MGC Pharmaceuticals share p...

Motley Fool MXC 1 month ago
MGC Pharmaceuticals receives go-ahead for Phase III trial of COVID-19 treatment

Medicinal cannabis biotech company MGC Pharmaceuticals (ASX:MXC) can proceed to a Phase III clinical trial of its anti-inflammatory medicine for the treatment of COVID-19. Ethics committees at Nazareth Hospital and the Rambam Health Care Ca...

Stockhead MXC 1 month ago
Huge shakeup expected as British American Tobacco makes a move on Canadian cannabis

The North American cannabis market received a huge shakeup this week, after British American Tobacco (LON: BATS) announced that it would be purchasing a 19.9% stake in the Canadian cannabis producer, Organigram (TSE: OGI), for $175 million....

Stockhead MXC 1 month ago
Weed Week: US pot legalisation picks up steam, and the Big Apple could be next

Pot legalisation is creeping across the US state by state, and a major market could be about to join their ranks. Reports out of New York indicate that lawmakers in the Empire State are close to signing a new bill legalising recreational ca...

Stockhead MXC 1 month ago
How are these 3 ASX cannabis penny shares performing - CAN, LGP, MXC?

Source: Stereo Lights, Shutterstock Summary The Australian cannabis industry is in an infant stage and can offer several opportunities to market participants with a keen interest in this space. Developer and supplier of cannabis produ...

Kalkine Media MXC 1 month ago
Six stocks under 20 cents doing well today

Source: ITTIGallery ,Shutterstock Summary Metalstech’s share price has shot up by 45.8 per cent after the announcement of its commercialization strategy. Nanoveu released updates regarding its suite of antiviral protection technologie...

Kalkine Media MXC 1 month ago
Anti-inflammatory product order boost for MGC

Bio-pharma group MGC Pharmaceuticals has received a much larger initial purchase order from European nutraceutical producer and distributor, Swiss PharmaCan for the ASX-listed outfit’s anti-inflammatory product, ArtemiC Rescue.

The West MXC 2 months ago
MGC Pharmaceuticals Shares Are Up after 85% increased PO (ASX:MXC)

The MGC Pharmaceuticals Ltd [ASX:MXC] share price is up after its leading European distributor increased purchase order volume of MGC’s ArtemiC by 85%. The MGC share price jumped 7% in early trading... The post MGC Pharmaceuticals Shares A...

MoneyMorning MXC 2 months ago
Up 310% the MGC Pharma (ASX:MXC) share price is gaining again today

The MGC Pharmaceuticals Ltd (ASX: MXC) share price is gaining today, up 2.5% in late morning trade. MGC Pharmaceuticals (MGC Pharma) is a biopharma company that produces and develops phytocannabinoid-derived medicines. This morning, it ann...

Motley Fool MXC 2 months ago
Here’s why MGC Pharmaceuticals (ASX:MXC) is trading higher today

Source: metamorworks,Shutterstock Summary MGC Pharmaceuticals has received an increased purchase order of ArtemiCTM Rescue from Swiss PharmaCan AG. The total order value now holds above $425,000, which would be translated to an immedi...

Kalkine Media MXC 2 months ago
MGC Pharmaceuticals says distributor has increased initial order for COVID-19 supplement 85%

"This further agreement will provide more people access to the natural therapeutic benefits of the supplement,” said managing director Roby Zomer

Proactive Investors MXC 2 months ago
MGC Pharmaceuticals reports strong financial position as it drives medical cannabis growth

Milestones during the period included an acquisition, first product shipments, expansion of manufacturing facilities and continued clinical progress

Proactive Investors MXC 2 months ago
Top Performing Penny Stocks of February 2021

Source: Shutterstock Summary Fast-paced economic recovery seems to be driving the popularity of penny stocks in February 2021.  The unemployment rate dropped by 0.2% during January 2021.  While Penny stocks offer significant growth p...

Kalkine Media MXC 2 months ago
Why the MGC Pharma (ASX:MXC) share price is 31% higher today

The MGC Pharmaceuticals Ltd (ASX: MXC) share price zoomed up more than 35% higher today off the back of a positive announcement released to the market yesterday.   In a strong finish at the close of trade today, the MCG Pharma share price...

Motley Fool MXC 2 months ago